fanta.bio Sample: CNhs12236
11551 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| Hcfc1 SRX22599848 | NIH/3T3 Embryonic fibroblast | 546 / 14262 (3.8%) | 360 / 142620 (0.3%) | −324.0 | −324.0 | 15.17 |
| Asxl1 SRX3341232 | ES cells Pluripotent stem cell | 2921 / 14262 (20.5%) | 2589 / 142620 (1.8%) | −324.0 | −324.0 | 11.28 |
| Eomes SRX4904815 | Natural killer cells Blood | 3722 / 14262 (26.1%) | 3600 / 142620 (2.5%) | −324.0 | −324.0 | 10.34 |
| Epitope tags SRX13233372 | Testis Gonad | 1315 / 14262 (9.2%) | 1318 / 142620 (0.9%) | −324.0 | −324.0 | 9.98 |
| Epitope tags SRX7884346 | Acute myeloid leukemia Blood | 843 / 14262 (5.9%) | 1164 / 142620 (0.8%) | −324.0 | −324.0 | 7.24 |
| GFP SRX8244566 | Hematopoietic progenitors Blood | 1187 / 14262 (8.3%) | 1655 / 142620 (1.2%) | −324.0 | −324.0 | 7.17 |
| Epitope tags SRX7884347 | Acute myeloid leukemia Blood | 912 / 14262 (6.4%) | 1322 / 142620 (0.9%) | −324.0 | −324.0 | 6.90 |
| Med1 SRX3729400 | Hematopoietic progenitors Blood | 918 / 14262 (6.4%) | 1371 / 142620 (1.0%) | −324.0 | −324.0 | 6.70 |
| Med1 SRX3729401 | Hematopoietic progenitors Blood | 881 / 14262 (6.2%) | 1381 / 142620 (1.0%) | −324.0 | −324.0 | 6.38 |
| Rag1 SRX1046534 | Thymocytes Blood | 1437 / 14262 (10.1%) | 2385 / 142620 (1.7%) | −324.0 | −324.0 | 6.03 |
| Brd4 SRX3729384 | Hematopoietic progenitors Blood | 1285 / 14262 (9.0%) | 2275 / 142620 (1.6%) | −324.0 | −324.0 | 5.65 |
| Brd4 SRX8934799 | B cells Blood | 1103 / 14262 (7.7%) | 2039 / 142620 (1.4%) | −324.0 | −324.0 | 5.41 |
| Ets1 SRX1881673 | B cells Blood | 1283 / 14262 (9.0%) | 2425 / 142620 (1.7%) | −324.0 | −324.0 | 5.29 |
| Rag2 SRX018809 | Thymocytes Blood | 1261 / 14262 (8.8%) | 2399 / 142620 (1.7%) | −324.0 | −324.0 | 5.26 |
| Spi1 SRX2499698 | Scid.adh.2c2 Blood | 1043 / 14262 (7.3%) | 1998 / 142620 (1.4%) | −324.0 | −324.0 | 5.22 |
| Ets1 SRX1881674 | B cells Blood | 1246 / 14262 (8.7%) | 2392 / 142620 (1.7%) | −324.0 | −324.0 | 5.21 |
| Rag1 SRX1046554 | Unclassified Unclassified | 1259 / 14262 (8.8%) | 2420 / 142620 (1.7%) | −324.0 | −324.0 | 5.20 |
| Brd4 SRX1465788 | B cells Blood | 1445 / 14262 (10.1%) | 2783 / 142620 (2.0%) | −324.0 | −324.0 | 5.19 |
| Med1 SRX206369 | Pro-B cells Blood | 1238 / 14262 (8.7%) | 2435 / 142620 (1.7%) | −324.0 | −324.0 | 5.08 |
| Bcl11b SRX12709527 | CD8+ T cells Blood | 1192 / 14262 (8.4%) | 2345 / 142620 (1.6%) | −324.0 | −324.0 | 5.08 |
| Epitope tags SRX3279733 | B cells Blood | 1692 / 14262 (11.9%) | 3365 / 142620 (2.4%) | −324.0 | −324.0 | 5.03 |
| Myc SRX2522382 | Lymphoma cell lines Blood | 1239 / 14262 (8.7%) | 2466 / 142620 (1.7%) | −324.0 | −324.0 | 5.02 |
| Nipbl SRX13845190 | Scid.adh.2c2 Blood | 1070 / 14262 (7.5%) | 2131 / 142620 (1.5%) | −324.0 | −324.0 | 5.02 |
| Asxl1 SRX3739259 | Bone Marrow Cells Blood | 1501 / 14262 (10.5%) | 3014 / 142620 (2.1%) | −324.0 | −324.0 | 4.98 |
| Brd4 SRX3113704 | CD4+ T cells Blood | 1282 / 14262 (9.0%) | 2577 / 142620 (1.8%) | −324.0 | −324.0 | 4.97 |
| Spi1 SRX2499719 | Scid.adh.2c2 Blood | 1160 / 14262 (8.1%) | 2333 / 142620 (1.6%) | −324.0 | −324.0 | 4.97 |
| Ets1 SRX2162542 | Pre-B cells Blood | 1168 / 14262 (8.2%) | 2373 / 142620 (1.7%) | −324.0 | −324.0 | 4.92 |
| Asxl1 SRX3739258 | Bone Marrow Cells Blood | 1733 / 14262 (12.2%) | 3573 / 142620 (2.5%) | −324.0 | −324.0 | 4.85 |
| Myc SRX5356999 | Naive B cells Blood | 1523 / 14262 (10.7%) | 3185 / 142620 (2.2%) | −324.0 | −324.0 | 4.78 |
| Men1 SRX415268 | Th2 Cells Blood | 1203 / 14262 (8.4%) | 2530 / 142620 (1.8%) | −324.0 | −324.0 | 4.75 |
| Rag2 SRX1046543 | Thymocytes Blood | 2140 / 14262 (15.0%) | 4515 / 142620 (3.2%) | −324.0 | −324.0 | 4.74 |
| Nipbl SRX5730168 | B cells Blood | 1196 / 14262 (8.4%) | 2526 / 142620 (1.8%) | −324.0 | −324.0 | 4.73 |
| Nipbl SRX5730170 | B cells Blood | 1171 / 14262 (8.2%) | 2475 / 142620 (1.7%) | −324.0 | −324.0 | 4.73 |
| Ets1 SRX5086093 | Th2 Cells Blood | 1316 / 14262 (9.2%) | 2817 / 142620 (2.0%) | −324.0 | −324.0 | 4.67 |
| Brd4 SRX3729385 | Hematopoietic progenitors Blood | 1318 / 14262 (9.2%) | 2851 / 142620 (2.0%) | −324.0 | −324.0 | 4.62 |
| Myc SRX2522383 | Lymphoma cell lines Blood | 1529 / 14262 (10.7%) | 3315 / 142620 (2.3%) | −324.0 | −324.0 | 4.61 |
| Nipbl SRX320067 | CD4 CD8 double positive cells Blood | 1273 / 14262 (8.9%) | 2809 / 142620 (2.0%) | −324.0 | −324.0 | 4.53 |
| Hdac1 SRX1815526 | B cells Blood | 1284 / 14262 (9.0%) | 2847 / 142620 (2.0%) | −324.0 | −324.0 | 4.51 |
| Smarca4 SRX7807054 | Embryonic liver Embryo | 1542 / 14262 (10.8%) | 3445 / 142620 (2.4%) | −324.0 | −324.0 | 4.48 |
| Med12 SRX5086066 | Th2 Cells Blood | 1457 / 14262 (10.2%) | 3256 / 142620 (2.3%) | −324.0 | −324.0 | 4.47 |
| Fli1 SRX1056338 | 416B Blood | 1292 / 14262 (9.1%) | 2905 / 142620 (2.0%) | −324.0 | −324.0 | 4.45 |
| Ets1 SRX5086097 | Th2 Cells Blood | 1553 / 14262 (10.9%) | 3503 / 142620 (2.5%) | −324.0 | −324.0 | 4.43 |
| Epitope tags SRX3219118 | RN2 Blood | 1416 / 14262 (9.9%) | 3194 / 142620 (2.2%) | −324.0 | −324.0 | 4.43 |
| Brd4 SRX7799914 | CH12 Blood | 1725 / 14262 (12.1%) | 3894 / 142620 (2.7%) | −324.0 | −324.0 | 4.43 |
| Epitope tags SRX8244557 | Hematopoietic progenitors Blood | 3255 / 14262 (22.8%) | 7359 / 142620 (5.2%) | −324.0 | −324.0 | 4.42 |
| N6amt1 SRX8338674 | Tumour organoids Others | 1251 / 14262 (8.8%) | 2855 / 142620 (2.0%) | −324.0 | −324.0 | 4.38 |
| Myc SRX5356998 | Naive B cells Blood | 1937 / 14262 (13.6%) | 4444 / 142620 (3.1%) | −324.0 | −324.0 | 4.36 |
| Myc SRX5357000 | Naive B cells Blood | 1855 / 14262 (13.0%) | 4263 / 142620 (3.0%) | −324.0 | −324.0 | 4.35 |
| Nipbl SRX5730166 | B cells Blood | 1608 / 14262 (11.3%) | 3697 / 142620 (2.6%) | −324.0 | −324.0 | 4.35 |
| Bcl11b SRX1677234 | Thymus Blood | 2064 / 14262 (14.5%) | 4750 / 142620 (3.3%) | −324.0 | −324.0 | 4.35 |
| Erg SRX310200 | Mast Cells Blood | 1512 / 14262 (10.6%) | 3483 / 142620 (2.4%) | −324.0 | −324.0 | 4.34 |
| Bcor SRX22719795 | Leukemia Blood | 1543 / 14262 (10.8%) | 3562 / 142620 (2.5%) | −324.0 | −324.0 | 4.33 |
| GFP SRX2486160 | C127 Breast | 1638 / 14262 (11.5%) | 3785 / 142620 (2.7%) | −324.0 | −324.0 | 4.33 |
| Kdm2b SRX22719856 | Leukemia Blood | 1801 / 14262 (12.6%) | 4189 / 142620 (2.9%) | −324.0 | −324.0 | 4.30 |
| Stat5a SRX2975359 | Natural killer cells Blood | 1302 / 14262 (9.1%) | 3037 / 142620 (2.1%) | −324.0 | −324.0 | 4.29 |
| Kmt2a SRX17605412 | Leukemia Blood | 1438 / 14262 (10.1%) | 3362 / 142620 (2.4%) | −324.0 | −324.0 | 4.28 |
| Pcgf1 DRX053276 | MEL Blood | 1235 / 14262 (8.7%) | 2889 / 142620 (2.0%) | −324.0 | −324.0 | 4.27 |
| Nipbl SRX13845191 | Scid.adh.2c2 Blood | 1622 / 14262 (11.4%) | 3821 / 142620 (2.7%) | −324.0 | −324.0 | 4.24 |
| Brd4 SRX3602867 | iPS cells Pluripotent stem cell | 1283 / 14262 (9.0%) | 3025 / 142620 (2.1%) | −324.0 | −324.0 | 4.24 |
| Ets1 SRX5086095 | Th2 Cells Blood | 1637 / 14262 (11.5%) | 3863 / 142620 (2.7%) | −324.0 | −324.0 | 4.24 |
| Ets1 SRX5086094 | Th2 Cells Blood | 2106 / 14262 (14.8%) | 5009 / 142620 (3.5%) | −324.0 | −324.0 | 4.20 |
| Rag2 SRX1046552 | B cells Blood | 2413 / 14262 (16.9%) | 5772 / 142620 (4.0%) | −324.0 | −324.0 | 4.18 |
| Nipbl SRX4895107 | CH12 Blood | 1686 / 14262 (11.8%) | 4040 / 142620 (2.8%) | −324.0 | −324.0 | 4.17 |
| Epitope tags SRX3279734 | B cells Blood | 2566 / 14262 (18.0%) | 6150 / 142620 (4.3%) | −324.0 | −324.0 | 4.17 |
| Epitope tags SRX2486172 | ES cells Pluripotent stem cell | 1382 / 14262 (9.7%) | 3329 / 142620 (2.3%) | −324.0 | −324.0 | 4.15 |
| Spin1 SRX2704849 | Myoblasts Muscle | 1623 / 14262 (11.4%) | 3919 / 142620 (2.7%) | −324.0 | −324.0 | 4.14 |
| Myc SRX353784 | B cells Blood | 1797 / 14262 (12.6%) | 4342 / 142620 (3.0%) | −324.0 | −324.0 | 4.14 |
| Kmt2a SRX17605406 | Granulocytic-monocytic progenitors Blood | 1895 / 14262 (13.3%) | 4584 / 142620 (3.2%) | −324.0 | −324.0 | 4.13 |
| Hdac1 SRX7726758 | B cells Blood | 1520 / 14262 (10.7%) | 3683 / 142620 (2.6%) | −324.0 | −324.0 | 4.13 |
| Rag2 SRX1046550 | B cells Blood | 2664 / 14262 (18.7%) | 6469 / 142620 (4.5%) | −324.0 | −324.0 | 4.12 |
| Nipbl SRX5730164 | CH12F3 Blood | 1526 / 14262 (10.7%) | 3716 / 142620 (2.6%) | −324.0 | −324.0 | 4.11 |
| Runx1 SRX2499764 | Scid.adh.2c2 Blood | 2067 / 14262 (14.5%) | 5040 / 142620 (3.5%) | −324.0 | −324.0 | 4.10 |
| Men1 SRX415267 | Th2 Cells Blood | 1648 / 14262 (11.6%) | 4019 / 142620 (2.8%) | −324.0 | −324.0 | 4.10 |
| Spi1 SRX2499699 | Scid.adh.2c2 Blood | 1860 / 14262 (13.0%) | 4537 / 142620 (3.2%) | −324.0 | −324.0 | 4.10 |
| Ep300 SRX15950933 | CD4+ T cells Blood | 1303 / 14262 (9.1%) | 3192 / 142620 (2.2%) | −324.0 | −324.0 | 4.08 |
| Nipbl SRX8694069 | B cells Blood | 1501 / 14262 (10.5%) | 3691 / 142620 (2.6%) | −324.0 | −324.0 | 4.07 |
| Runx1 SRX1438366 | EML Blood | 2319 / 14262 (16.3%) | 5708 / 142620 (4.0%) | −324.0 | −324.0 | 4.06 |
| Nipbl SRX5730169 | B cells Blood | 1621 / 14262 (11.4%) | 4004 / 142620 (2.8%) | −324.0 | −324.0 | 4.05 |
| Runx1 SRX5358496 | Pro-B cells Blood | 2704 / 14262 (19.0%) | 6682 / 142620 (4.7%) | −324.0 | −324.0 | 4.05 |
| Bcl11b SRX1649982 | Thymus Blood | 2216 / 14262 (15.5%) | 5478 / 142620 (3.8%) | −324.0 | −324.0 | 4.05 |
| Rad21 SRX7481995 | Pro-B cells Blood | 1555 / 14262 (10.9%) | 3846 / 142620 (2.7%) | −324.0 | −324.0 | 4.04 |
| Rag2 SRX1046542 | Thymocytes Blood | 2789 / 14262 (19.6%) | 6914 / 142620 (4.8%) | −324.0 | −324.0 | 4.03 |
| Tet2 SRX1387481 | MEL Blood | 1402 / 14262 (9.8%) | 3476 / 142620 (2.4%) | −324.0 | −324.0 | 4.03 |
| Med12 SRX5086068 | Th2 Cells Blood | 1375 / 14262 (9.6%) | 3412 / 142620 (2.4%) | −324.0 | −324.0 | 4.03 |
| Spi1 SRX5507842 | Spleen and lymph nodes Blood | 1310 / 14262 (9.2%) | 3255 / 142620 (2.3%) | −324.0 | −324.0 | 4.02 |
| Ets1 SRX5086099 | Th2 Cells Blood | 2009 / 14262 (14.1%) | 5000 / 142620 (3.5%) | −324.0 | −324.0 | 4.02 |
| Rad21 SRX23052807 | mESC derived neural cells Pluripotent stem cell | 1348 / 14262 (9.5%) | 3362 / 142620 (2.4%) | −324.0 | −324.0 | 4.01 |
| Cxxc1 SRX2486179 | ES cells Pluripotent stem cell | 1337 / 14262 (9.4%) | 3345 / 142620 (2.3%) | −324.0 | −324.0 | 4.00 |
| Nipbl SRX5730171 | B cells Blood | 1641 / 14262 (11.5%) | 4126 / 142620 (2.9%) | −324.0 | −324.0 | 3.98 |
| Spi1 SRX2499700 | Scid.adh.2c2 Blood | 1516 / 14262 (10.6%) | 3830 / 142620 (2.7%) | −324.0 | −324.0 | 3.96 |
| Nipbl SRX8694068 | B cells Blood | 1359 / 14262 (9.5%) | 3440 / 142620 (2.4%) | −324.0 | −324.0 | 3.95 |
| Cbfb SRX5780111 | CD8+ T cells Blood | 1650 / 14262 (11.6%) | 4177 / 142620 (2.9%) | −324.0 | −324.0 | 3.95 |
| Cbfb SRX2389671 | Embryonic liver Embryo | 1822 / 14262 (12.8%) | 4614 / 142620 (3.2%) | −324.0 | −324.0 | 3.95 |
| Kmt2a SRX22719786 | Leukemia Blood | 1436 / 14262 (10.1%) | 3637 / 142620 (2.6%) | −324.0 | −324.0 | 3.95 |
| Runx1 SRX2499765 | Scid.adh.2c2 Blood | 1687 / 14262 (11.8%) | 4282 / 142620 (3.0%) | −324.0 | −324.0 | 3.94 |
| Bcl11b SRX18851332 | Thymocytes Blood | 2200 / 14262 (15.4%) | 5589 / 142620 (3.9%) | −324.0 | −324.0 | 3.94 |
| Myc SRX353783 | B cells Blood | 2328 / 14262 (16.3%) | 5918 / 142620 (4.1%) | −324.0 | −324.0 | 3.93 |
| Runx3 SRX8718716 | T progenitor cells Blood | 1567 / 14262 (11.0%) | 3988 / 142620 (2.8%) | −324.0 | −324.0 | 3.93 |
| Runx3 SRX8718739 | T progenitor cells Blood | 1519 / 14262 (10.7%) | 3867 / 142620 (2.7%) | −324.0 | −324.0 | 3.93 |
| Bach2 SRX2200546 | Pro-B cells Blood | 1578 / 14262 (11.1%) | 4043 / 142620 (2.8%) | −324.0 | −324.0 | 3.90 |
| Nipbl SRX5730167 | B cells Blood | 1556 / 14262 (10.9%) | 3988 / 142620 (2.8%) | −324.0 | −324.0 | 3.90 |
| Rag2 SRX1046541 | Thymocytes Blood | 2897 / 14262 (20.3%) | 7428 / 142620 (5.2%) | −324.0 | −324.0 | 3.90 |
| Nipbl SRX8694070 | B cells Blood | 1354 / 14262 (9.5%) | 3474 / 142620 (2.4%) | −324.0 | −324.0 | 3.90 |
| Bcl11b SRX1677239 | Thymus Blood | 2147 / 14262 (15.1%) | 5514 / 142620 (3.9%) | −324.0 | −324.0 | 3.89 |
| Ets1 SRX5086098 | Th2 Cells Blood | 2379 / 14262 (16.7%) | 6110 / 142620 (4.3%) | −324.0 | −324.0 | 3.89 |
| GFP SRX2486159 | C127 Breast | 1950 / 14262 (13.7%) | 5013 / 142620 (3.5%) | −324.0 | −324.0 | 3.89 |
| Foxp1 SRX20851844 | CD8+ T cells Blood | 1567 / 14262 (11.0%) | 4045 / 142620 (2.8%) | −324.0 | −324.0 | 3.87 |
| Nipbl SRX3753617 | B cells Blood | 2101 / 14262 (14.7%) | 5453 / 142620 (3.8%) | −324.0 | −324.0 | 3.85 |
| Pax5 SRX19312223 | Pro-B cells Blood | 1775 / 14262 (12.4%) | 4617 / 142620 (3.2%) | −324.0 | −324.0 | 3.84 |
| Stat4 SRX7726477 | Natural killer cells Blood | 1584 / 14262 (11.1%) | 4124 / 142620 (2.9%) | −324.0 | −324.0 | 3.84 |
| Bcor SRX22719796 | Leukemia Blood | 2094 / 14262 (14.7%) | 5456 / 142620 (3.8%) | −324.0 | −324.0 | 3.84 |
| Kdm2b SRX22719855 | Leukemia Blood | 2329 / 14262 (16.3%) | 6081 / 142620 (4.3%) | −324.0 | −324.0 | 3.83 |
| Foxp1 SRX20851843 | CD8+ T cells Blood | 1479 / 14262 (10.4%) | 3867 / 142620 (2.7%) | −324.0 | −324.0 | 3.82 |
| Nipbl SRX8694063 | T cells Blood | 2030 / 14262 (14.2%) | 5320 / 142620 (3.7%) | −324.0 | −324.0 | 3.82 |
| Bcl11b SRX2487650 | CD4 CD8 double negative cells Blood | 2477 / 14262 (17.4%) | 6504 / 142620 (4.6%) | −324.0 | −324.0 | 3.81 |
| Rbfox2 SRX551545 | MEF Embryonic fibroblast | 1679 / 14262 (11.8%) | 4412 / 142620 (3.1%) | −324.0 | −324.0 | 3.81 |
| Brd4 SRX7799919 | CH12 Blood | 2181 / 14262 (15.3%) | 5762 / 142620 (4.0%) | −324.0 | −324.0 | 3.79 |
| Runx1 SRX2789670 | Natural Killer T-Cells Blood | 1763 / 14262 (12.4%) | 4663 / 142620 (3.3%) | −324.0 | −324.0 | 3.78 |
| Bcl11b SRX18851331 | Thymocytes Blood | 2170 / 14262 (15.2%) | 5742 / 142620 (4.0%) | −324.0 | −324.0 | 3.78 |
| Sin3a SRX22262965 | Beta-TC-6 Pancreas | 1562 / 14262 (11.0%) | 4139 / 142620 (2.9%) | −324.0 | −324.0 | 3.77 |
| Bcl11b SRX18851333 | Thymocytes Blood | 2264 / 14262 (15.9%) | 6001 / 142620 (4.2%) | −324.0 | −324.0 | 3.77 |
| Nipbl SRX8694065 | B cells Blood | 2036 / 14262 (14.3%) | 5397 / 142620 (3.8%) | −324.0 | −324.0 | 3.77 |
| Nipbl SRX4895127 | CH12 Blood | 2466 / 14262 (17.3%) | 6556 / 142620 (4.6%) | −324.0 | −324.0 | 3.76 |
| Nipbl SRX8694067 | B cells Blood | 1554 / 14262 (10.9%) | 4134 / 142620 (2.9%) | −324.0 | −324.0 | 3.76 |
| Ets1 SRX2499706 | Scid.adh.2c2 Blood | 2555 / 14262 (17.9%) | 6808 / 142620 (4.8%) | −324.0 | −324.0 | 3.75 |
| Rag2 SRX1046545 | Thymocytes Blood | 2984 / 14262 (20.9%) | 7967 / 142620 (5.6%) | −324.0 | −324.0 | 3.75 |
| Bcl11b SRX2487652 | CD4 CD8 double negative cells Blood | 2838 / 14262 (19.9%) | 7592 / 142620 (5.3%) | −324.0 | −324.0 | 3.74 |
| Nfib SRX19694890 | C3H/10T1/2 Embryonic fibroblast | 1409 / 14262 (9.9%) | 3771 / 142620 (2.6%) | −324.0 | −324.0 | 3.74 |
| Myc SRX353785 | B cells Blood | 2300 / 14262 (16.1%) | 6162 / 142620 (4.3%) | −324.0 | −324.0 | 3.73 |
| Ets1 SRX2499705 | Scid.adh.2c2 Blood | 2598 / 14262 (18.2%) | 6968 / 142620 (4.9%) | −324.0 | −324.0 | 3.73 |
| Hdac1 SRX9519542 | G1E Blood | 2042 / 14262 (14.3%) | 5478 / 142620 (3.8%) | −324.0 | −324.0 | 3.73 |
| Pax5 SRX19312225 | Pro-B cells Blood | 1816 / 14262 (12.7%) | 4875 / 142620 (3.4%) | −324.0 | −324.0 | 3.73 |
| Rag2 SRX1046553 | B cells Blood | 3007 / 14262 (21.1%) | 8098 / 142620 (5.7%) | −324.0 | −324.0 | 3.71 |
| Egr2 SRX270570 | CD4+ T cells Blood | 1487 / 14262 (10.4%) | 4013 / 142620 (2.8%) | −324.0 | −324.0 | 3.71 |
| Fli1 SRX4705104 | MLL-AF9 leukemic cell Blood | 1484 / 14262 (10.4%) | 4013 / 142620 (2.8%) | −324.0 | −324.0 | 3.70 |
| Tcf3 SRX2162541 | Pre-B cells Blood | 1823 / 14262 (12.8%) | 4933 / 142620 (3.5%) | −324.0 | −324.0 | 3.70 |
| Nelfe SRX140395 | MEL Blood | 1525 / 14262 (10.7%) | 4128 / 142620 (2.9%) | −324.0 | −324.0 | 3.69 |
| Runx1 SRX1438367 | EML Blood | 2598 / 14262 (18.2%) | 7038 / 142620 (4.9%) | −324.0 | −324.0 | 3.69 |
| Sin3a SRX22262966 | Beta-TC-6 Pancreas | 1621 / 14262 (11.4%) | 4397 / 142620 (3.1%) | −324.0 | −324.0 | 3.69 |
| Ets1 SRX2499704 | Scid.adh.2c2 Blood | 2565 / 14262 (18.0%) | 6962 / 142620 (4.9%) | −324.0 | −324.0 | 3.68 |
| Pax5 SRX11976741 | Pro-B cells Blood | 2278 / 14262 (16.0%) | 6221 / 142620 (4.4%) | −324.0 | −324.0 | 3.66 |
| Ep300 SRX25655383 | Leukemia Blood | 1520 / 14262 (10.7%) | 4154 / 142620 (2.9%) | −324.0 | −324.0 | 3.66 |
| Brd4 SRX376583 | MLL-AF9 leukemic cell Blood | 1961 / 14262 (13.7%) | 5379 / 142620 (3.8%) | −324.0 | −324.0 | 3.65 |
| Nipbl SRX3753614 | B cells Blood | 1594 / 14262 (11.2%) | 4375 / 142620 (3.1%) | −324.0 | −324.0 | 3.64 |
| Ikzf3 SRX10166890 | Thymocytes Blood | 2004 / 14262 (14.1%) | 5506 / 142620 (3.9%) | −324.0 | −324.0 | 3.64 |
| Kdm6b SRX621433 | CD4+ T cells Blood | 1696 / 14262 (11.9%) | 4661 / 142620 (3.3%) | −324.0 | −324.0 | 3.64 |
| Spi1 SRX091672 | CD4 CD8 double negative cells Blood | 1652 / 14262 (11.6%) | 4543 / 142620 (3.2%) | −324.0 | −324.0 | 3.64 |
| Fli1 SRX1939439 | Lymphoid-primed multipotent progenitors Blood | 1701 / 14262 (11.9%) | 4686 / 142620 (3.3%) | −324.0 | −324.0 | 3.63 |
| Cbfb SRX2389673 | Thymocytes Blood | 2052 / 14262 (14.4%) | 5654 / 142620 (4.0%) | −324.0 | −324.0 | 3.63 |
| Med26 SRX20509320 | CH12 Blood | 1947 / 14262 (13.7%) | 5371 / 142620 (3.8%) | −324.0 | −324.0 | 3.63 |
| Fli1 SRX7821115 | Hematopoietic progenitors Blood | 1698 / 14262 (11.9%) | 4687 / 142620 (3.3%) | −324.0 | −324.0 | 3.62 |
| Wdr5 SRX1815529 | B cells Blood | 1751 / 14262 (12.3%) | 4840 / 142620 (3.4%) | −324.0 | −324.0 | 3.62 |
| Nipbl SRX2755276 | B cells Blood | 2301 / 14262 (16.1%) | 6364 / 142620 (4.5%) | −324.0 | −324.0 | 3.62 |
| Bcor SRX22719813 | Leukemia Blood | 1706 / 14262 (12.0%) | 4727 / 142620 (3.3%) | −324.0 | −324.0 | 3.61 |
| Bcl11b SRX18851328 | Thymocytes Blood | 2077 / 14262 (14.6%) | 5759 / 142620 (4.0%) | −324.0 | −324.0 | 3.61 |
| Hdac1 SRX7726755 | B cells Blood | 1756 / 14262 (12.3%) | 4883 / 142620 (3.4%) | −324.0 | −324.0 | 3.60 |
| Fli1 SRX310201 | Mast Cells Blood | 1881 / 14262 (13.2%) | 5232 / 142620 (3.7%) | −324.0 | −324.0 | 3.60 |
| Runx3 SRX8718717 | T progenitor cells Blood | 1981 / 14262 (13.9%) | 5526 / 142620 (3.9%) | −324.0 | −324.0 | 3.58 |
| Runx1 SRX5358492 | Pro-B cells Blood | 3048 / 14262 (21.4%) | 8536 / 142620 (6.0%) | −324.0 | −324.0 | 3.57 |
| Hdac1 SRX9519543 | G1E Blood | 2236 / 14262 (15.7%) | 6270 / 142620 (4.4%) | −324.0 | −324.0 | 3.57 |
| Kmt2a SRX17605411 | Leukemia Blood | 2136 / 14262 (15.0%) | 5990 / 142620 (4.2%) | −324.0 | −324.0 | 3.57 |
| Yy1 SRX14617702 | CH12 Blood | 1750 / 14262 (12.3%) | 4910 / 142620 (3.4%) | −324.0 | −324.0 | 3.56 |
| Runx1 SRX5358488 | Pro-B cells Blood | 1861 / 14262 (13.0%) | 5230 / 142620 (3.7%) | −324.0 | −324.0 | 3.56 |
| Nipbl SRX8694066 | B cells Blood | 1540 / 14262 (10.8%) | 4333 / 142620 (3.0%) | −324.0 | −324.0 | 3.55 |
| Tbp SRX22599847 | NIH/3T3 Embryonic fibroblast | 2006 / 14262 (14.1%) | 5648 / 142620 (4.0%) | −324.0 | −324.0 | 3.55 |
| Spi1 SRX5026211 | Mast Cells Blood | 1505 / 14262 (10.6%) | 4254 / 142620 (3.0%) | −324.0 | −324.0 | 3.54 |
| Nipbl SRX2755277 | B cells Blood | 2619 / 14262 (18.4%) | 7414 / 142620 (5.2%) | −324.0 | −324.0 | 3.53 |
| Bach2 SRX2200545 | Pro-B cells Blood | 1761 / 14262 (12.3%) | 4993 / 142620 (3.5%) | −324.0 | −324.0 | 3.53 |
| Runx1 SRX2499762 | Scid.adh.2c2 Blood | 2109 / 14262 (14.8%) | 5981 / 142620 (4.2%) | −324.0 | −324.0 | 3.53 |
| Mllt3 SRX1902738 | Acute myeloid leukemia Blood | 2085 / 14262 (14.6%) | 5916 / 142620 (4.1%) | −324.0 | −324.0 | 3.52 |
| Spi1 SRX2499724 | Scid.adh.2c2 Blood | 1652 / 14262 (11.6%) | 4692 / 142620 (3.3%) | −324.0 | −324.0 | 3.52 |
| Pax5 SRX19312224 | Pro-B cells Blood | 2370 / 14262 (16.6%) | 6736 / 142620 (4.7%) | −324.0 | −324.0 | 3.52 |
| Nipbl SRX3753616 | B cells Blood | 2501 / 14262 (17.5%) | 7130 / 142620 (5.0%) | −324.0 | −324.0 | 3.51 |
| Nipbl SRX4895128 | CH12 Blood | 2747 / 14262 (19.3%) | 7906 / 142620 (5.5%) | −324.0 | −324.0 | 3.47 |
| Crebbp SRX25655381 | Leukemia Blood | 1838 / 14262 (12.9%) | 5300 / 142620 (3.7%) | −324.0 | −324.0 | 3.47 |
| Spi1 SRX2499701 | Scid.adh.2c2 Blood | 1783 / 14262 (12.5%) | 5166 / 142620 (3.6%) | −324.0 | −324.0 | 3.45 |
| Pax5 SRX7809236 | Pro-B cells Blood | 1670 / 14262 (11.7%) | 4841 / 142620 (3.4%) | −324.0 | −324.0 | 3.45 |
| Zfp281 SRX16019903 | Th2 Cells Blood | 1827 / 14262 (12.8%) | 5306 / 142620 (3.7%) | −324.0 | −324.0 | 3.44 |
| Hdac1 SRX1815525 | B cells Blood | 2869 / 14262 (20.1%) | 8339 / 142620 (5.8%) | −324.0 | −324.0 | 3.44 |
| Bcl11b SRX18851329 | Thymocytes Blood | 2563 / 14262 (18.0%) | 7457 / 142620 (5.2%) | −324.0 | −324.0 | 3.44 |
| Nfib SRX19694891 | C3H/10T1/2 Embryonic fibroblast | 1994 / 14262 (14.0%) | 5804 / 142620 (4.1%) | −324.0 | −324.0 | 3.44 |
| Stat5a SRX15950931 | CD4+ T cells Blood | 1866 / 14262 (13.1%) | 5440 / 142620 (3.8%) | −324.0 | −324.0 | 3.43 |
| Nfib SRX19694893 | C3H/10T1/2 Embryonic fibroblast | 1913 / 14262 (13.4%) | 5580 / 142620 (3.9%) | −324.0 | −324.0 | 3.43 |
| Rbfox2 SRX551553 | MEF Embryonic fibroblast | 1627 / 14262 (11.4%) | 4749 / 142620 (3.3%) | −324.0 | −324.0 | 3.43 |
| Spi1 SRX091673 | CD4 CD8 double negative cells Blood | 1656 / 14262 (11.6%) | 4839 / 142620 (3.4%) | −324.0 | −324.0 | 3.42 |
| Nfib SRX19694889 | C3H/10T1/2 Embryonic fibroblast | 1851 / 14262 (13.0%) | 5409 / 142620 (3.8%) | −324.0 | −324.0 | 3.42 |
| Mta2 SRX1205896 | CD4 CD8 double negative cells Blood | 2516 / 14262 (17.6%) | 7359 / 142620 (5.2%) | −324.0 | −324.0 | 3.42 |
| Nipbl SRX8694064 | T cells Blood | 2122 / 14262 (14.9%) | 6222 / 142620 (4.4%) | −324.0 | −324.0 | 3.41 |
| Bcl11b SRX3660780 | CD4 CD8 double negative cells Blood | 3164 / 14262 (22.2%) | 9281 / 142620 (6.5%) | −324.0 | −324.0 | 3.41 |
| Gata3 SRX2499768 | Scid.adh.2c2 Blood | 1722 / 14262 (12.1%) | 5053 / 142620 (3.5%) | −324.0 | −324.0 | 3.41 |
| Kdm2b SRX22719876 | Leukemia Blood | 2156 / 14262 (15.1%) | 6331 / 142620 (4.4%) | −324.0 | −324.0 | 3.41 |
| Bcl11b SRX18851330 | Thymocytes Blood | 2507 / 14262 (17.6%) | 7364 / 142620 (5.2%) | −324.0 | −324.0 | 3.40 |
| Nfib SRX19694894 | C3H/10T1/2 Embryonic fibroblast | 2072 / 14262 (14.5%) | 6091 / 142620 (4.3%) | −324.0 | −324.0 | 3.40 |
| Hdac2 SRX3660790 | Scid.adh.2c2 Blood | 2331 / 14262 (16.3%) | 6855 / 142620 (4.8%) | −324.0 | −324.0 | 3.40 |
| Smarca4 SRX7807053 | Embryonic liver Embryo | 2344 / 14262 (16.4%) | 6915 / 142620 (4.8%) | −324.0 | −324.0 | 3.39 |
| Smarca4 SRX7807050 | Embryonic liver Embryo | 2482 / 14262 (17.4%) | 7328 / 142620 (5.1%) | −324.0 | −324.0 | 3.39 |
| Pax5 SRX5358483 | Pro-B cells Blood | 1579 / 14262 (11.1%) | 4666 / 142620 (3.3%) | −324.0 | −324.0 | 3.38 |
| Hdac1 SRX7726756 | B cells Blood | 1884 / 14262 (13.2%) | 5571 / 142620 (3.9%) | −324.0 | −324.0 | 3.38 |
| Brd4 SRX8379041 | Macrophages Blood | 1789 / 14262 (12.5%) | 5299 / 142620 (3.7%) | −324.0 | −324.0 | 3.38 |
| Kmt2a SRX1815528 | B cells Blood | 2655 / 14262 (18.6%) | 7890 / 142620 (5.5%) | −324.0 | −324.0 | 3.37 |
| Runx1 SRX5358482 | Pro-B cells Blood | 3187 / 14262 (22.3%) | 9483 / 142620 (6.6%) | −324.0 | −324.0 | 3.36 |
| Brd4 SRX8379040 | Macrophages Blood | 1766 / 14262 (12.4%) | 5264 / 142620 (3.7%) | −324.0 | −324.0 | 3.35 |
| Rnf2 SRX9633976 | B cells Blood | 1902 / 14262 (13.3%) | 5700 / 142620 (4.0%) | −324.0 | −324.0 | 3.34 |
| Nipbl SRX4895106 | CH12 Blood | 2669 / 14262 (18.7%) | 8001 / 142620 (5.6%) | −324.0 | −324.0 | 3.34 |
| Taf1 SRX19028407 | ES cells Pluripotent stem cell | 1694 / 14262 (11.9%) | 5090 / 142620 (3.6%) | −324.0 | −324.0 | 3.33 |
| Tfap4 SRX554972 | CD8+ T cells Blood | 1749 / 14262 (12.3%) | 5259 / 142620 (3.7%) | −324.0 | −324.0 | 3.33 |
| Yy1 SRX14617670 | CH12 Blood | 2311 / 14262 (16.2%) | 6960 / 142620 (4.9%) | −324.0 | −324.0 | 3.32 |
| Runx1 SRX3195533 | CD4 CD8 double negative cells Blood | 2288 / 14262 (16.0%) | 6895 / 142620 (4.8%) | −324.0 | −324.0 | 3.32 |
| Mta2 SRX3660756 | CD4 CD8 double negative cells Blood | 1724 / 14262 (12.1%) | 5202 / 142620 (3.6%) | −324.0 | −324.0 | 3.31 |
| Hdac2 SRX3660789 | Scid.adh.2c2 Blood | 2583 / 14262 (18.1%) | 7794 / 142620 (5.5%) | −324.0 | −324.0 | 3.31 |
| Kmt2a SRX1815514 | B cells Blood | 2799 / 14262 (19.6%) | 8472 / 142620 (5.9%) | −324.0 | −324.0 | 3.30 |
| Pax5 SRX19312226 | Pro-B cells Blood | 2298 / 14262 (16.1%) | 6978 / 142620 (4.9%) | −324.0 | −324.0 | 3.29 |
| Rnf2 SRX9633974 | B cells Blood | 2123 / 14262 (14.9%) | 6455 / 142620 (4.5%) | −324.0 | −324.0 | 3.29 |
| Epitope tags SRX3219123 | RN2 Blood | 2724 / 14262 (19.1%) | 8288 / 142620 (5.8%) | −324.0 | −324.0 | 3.29 |
| Nr3c1 SRX4615042 | Lung endothelial cells Cardiovascular | 1983 / 14262 (13.9%) | 6042 / 142620 (4.2%) | −324.0 | −324.0 | 3.28 |
| Bcl11b SRX3660779 | CD4 CD8 double negative cells Blood | 3425 / 14262 (24.0%) | 10438 / 142620 (7.3%) | −324.0 | −324.0 | 3.28 |
| Chd4 SRX1815523 | B cells Blood | 2876 / 14262 (20.2%) | 8768 / 142620 (6.1%) | −324.0 | −324.0 | 3.28 |
| Yy1 SRX14617672 | CH12 Blood | 2364 / 14262 (16.6%) | 7218 / 142620 (5.1%) | −324.0 | −324.0 | 3.28 |
| Spi1 SRX5026216 | Mast Cells Blood | 1799 / 14262 (12.6%) | 5497 / 142620 (3.9%) | −324.0 | −324.0 | 3.27 |
| Cbfb SRX2389674 | Thymocytes Blood | 3276 / 14262 (23.0%) | 10032 / 142620 (7.0%) | −324.0 | −324.0 | 3.27 |
| GFP SRX8244559 | Hematopoietic progenitors Blood | 3494 / 14262 (24.5%) | 10700 / 142620 (7.5%) | −324.0 | −324.0 | 3.27 |
| Sap130 SRX1568882 | Embryonic heart Embryo | 2087 / 14262 (14.6%) | 6422 / 142620 (4.5%) | −324.0 | −324.0 | 3.25 |
| Spi1 SRX7692793 | Eosinophils Blood | 1712 / 14262 (12.0%) | 5276 / 142620 (3.7%) | −324.0 | −324.0 | 3.24 |
| Runx3 SRX8718740 | T progenitor cells Blood | 2617 / 14262 (18.3%) | 8067 / 142620 (5.7%) | −324.0 | −324.0 | 3.24 |
| Ikzf3 SRX10166891 | Thymocytes Blood | 2029 / 14262 (14.2%) | 6255 / 142620 (4.4%) | −324.0 | −324.0 | 3.24 |
| Kdm6b SRX621429 | CD4+ T cells Blood | 3091 / 14262 (21.7%) | 9542 / 142620 (6.7%) | −324.0 | −324.0 | 3.24 |
| Cbfb SRX2389672 | Thymocytes Blood | 3350 / 14262 (23.5%) | 10344 / 142620 (7.3%) | −324.0 | −324.0 | 3.24 |
| Pax5 SRX5358487 | Pro-B cells Blood | 1831 / 14262 (12.8%) | 5658 / 142620 (4.0%) | −324.0 | −324.0 | 3.24 |
| Spi1 SRX2499686 | CD25+ cells Blood | 2436 / 14262 (17.1%) | 7541 / 142620 (5.3%) | −324.0 | −324.0 | 3.23 |
| Nr3c1 SRX4615041 | Lung endothelial cells Cardiovascular | 1929 / 14262 (13.5%) | 5979 / 142620 (4.2%) | −324.0 | −324.0 | 3.23 |
| Nipbl SRX3753615 | B cells Blood | 2440 / 14262 (17.1%) | 7566 / 142620 (5.3%) | −324.0 | −324.0 | 3.22 |
| Runx2 SRX4705109 | MLL-AF9 leukemic cell Blood | 2133 / 14262 (15.0%) | 6630 / 142620 (4.6%) | −324.0 | −324.0 | 3.22 |
| Pax5 SRX11976740 | Pro-B cells Blood | 2139 / 14262 (15.0%) | 6668 / 142620 (4.7%) | −324.0 | −324.0 | 3.21 |
| Spi1 SRX2499722 | Scid.adh.2c2 Blood | 1839 / 14262 (12.9%) | 5734 / 142620 (4.0%) | −324.0 | −324.0 | 3.21 |
| Stat4 SRX7726479 | Natural killer cells Blood | 2106 / 14262 (14.8%) | 6580 / 142620 (4.6%) | −324.0 | −324.0 | 3.20 |
| Rnf2 SRX9633975 | B cells Blood | 2289 / 14262 (16.0%) | 7168 / 142620 (5.0%) | −324.0 | −324.0 | 3.19 |
| Pax5 SRX10950551 | Pro-B cells Blood | 1968 / 14262 (13.8%) | 6175 / 142620 (4.3%) | −324.0 | −324.0 | 3.19 |
| Kdm2b SRX22719877 | Leukemia Blood | 2911 / 14262 (20.4%) | 9136 / 142620 (6.4%) | −324.0 | −324.0 | 3.19 |
| Kdm4c SRX1755829 | Granulocytic-monocytic progenitors Blood | 2002 / 14262 (14.0%) | 6295 / 142620 (4.4%) | −324.0 | −324.0 | 3.18 |
| Hdac2 SRX1815527 | B cells Blood | 2933 / 14262 (20.6%) | 9224 / 142620 (6.5%) | −324.0 | −324.0 | 3.18 |
| Smarca4 SRX7807052 | Embryonic liver Embryo | 2830 / 14262 (19.8%) | 8930 / 142620 (6.3%) | −324.0 | −324.0 | 3.17 |
| Mta2 SRX3660755 | CD4 CD8 double negative cells Blood | 1872 / 14262 (13.1%) | 5908 / 142620 (4.1%) | −324.0 | −324.0 | 3.17 |
| Stat4 SRX7726478 | Natural killer cells Blood | 2262 / 14262 (15.9%) | 7143 / 142620 (5.0%) | −324.0 | −324.0 | 3.17 |
| Kdm2b SRX22719878 | Leukemia Blood | 1790 / 14262 (12.6%) | 5657 / 142620 (4.0%) | −324.0 | −324.0 | 3.16 |
| Rnf2 SRX3660767 | CD4 CD8 double negative cells Blood | 2037 / 14262 (14.3%) | 6441 / 142620 (4.5%) | −324.0 | −324.0 | 3.16 |
| Yy1 SRX14617671 | CH12 Blood | 2456 / 14262 (17.2%) | 7785 / 142620 (5.5%) | −324.0 | −324.0 | 3.15 |
| Phf8 SRX2396659 | Prostate Prostate | 2020 / 14262 (14.2%) | 6415 / 142620 (4.5%) | −324.0 | −324.0 | 3.15 |
| Bcl11b SRX12709528 | CD8+ T cells Blood | 1896 / 14262 (13.3%) | 6027 / 142620 (4.2%) | −324.0 | −324.0 | 3.15 |
| Yy1 SRX14617701 | CH12 Blood | 2380 / 14262 (16.7%) | 7571 / 142620 (5.3%) | −324.0 | −324.0 | 3.14 |
| Spi1 SRX5026210 | Mast Cells Blood | 2178 / 14262 (15.3%) | 6929 / 142620 (4.9%) | −324.0 | −324.0 | 3.14 |
| Runx2 SRX4705110 | MLL-AF9 leukemic cell Blood | 2170 / 14262 (15.2%) | 6906 / 142620 (4.8%) | −324.0 | −324.0 | 3.14 |
| Foxp3 SRX2341417 | Treg Blood | 1746 / 14262 (12.2%) | 5576 / 142620 (3.9%) | −324.0 | −324.0 | 3.13 |
| Smarca4 SRX7807051 | Embryonic liver Embryo | 2987 / 14262 (20.9%) | 9541 / 142620 (6.7%) | −324.0 | −324.0 | 3.13 |
| Spi1 SRX2499725 | Scid.adh.2c2 Blood | 2022 / 14262 (14.2%) | 6461 / 142620 (4.5%) | −324.0 | −324.0 | 3.13 |
| Yy1 SRX14617700 | CH12 Blood | 2366 / 14262 (16.6%) | 7620 / 142620 (5.3%) | −324.0 | −324.0 | 3.10 |
| Spi1 SRX2499721 | Scid.adh.2c2 Blood | 2036 / 14262 (14.3%) | 6558 / 142620 (4.6%) | −324.0 | −324.0 | 3.10 |
| Gfi1 SRX5131513 | Medulloblastoma Neural | 1851 / 14262 (13.0%) | 5986 / 142620 (4.2%) | −324.0 | −324.0 | 3.09 |
| Satb1 SRX13440924 | Thymus Blood | 2062 / 14262 (14.5%) | 6673 / 142620 (4.7%) | −324.0 | −324.0 | 3.09 |
| Gata3 SRX2499769 | Scid.adh.2c2 Blood | 2416 / 14262 (16.9%) | 7833 / 142620 (5.5%) | −324.0 | −324.0 | 3.08 |
| Runx1 SRX3195535 | CD4 CD8 double negative cells Blood | 2703 / 14262 (19.0%) | 8765 / 142620 (6.1%) | −324.0 | −324.0 | 3.08 |
| Smarca4 SRX1815522 | B cells Blood | 3388 / 14262 (23.8%) | 11042 / 142620 (7.7%) | −324.0 | −324.0 | 3.07 |
| Mxi1 SRX140388 | CH12 Blood | 2197 / 14262 (15.4%) | 7163 / 142620 (5.0%) | −324.0 | −324.0 | 3.07 |
| Irf4 SRX2162565 | Pre-B cells Blood | 2352 / 14262 (16.5%) | 7686 / 142620 (5.4%) | −324.0 | −324.0 | 3.06 |
| Spi1 SRX2499687 | CD25+ cells Blood | 2448 / 14262 (17.2%) | 8008 / 142620 (5.6%) | −324.0 | −324.0 | 3.06 |
| Lmo2 SRX7821114 | Hematopoietic progenitors Blood | 2115 / 14262 (14.8%) | 6930 / 142620 (4.9%) | −324.0 | −324.0 | 3.05 |
| Brd4 SRX1114541 | MLL-AF9 leukemic cell Blood | 3385 / 14262 (23.7%) | 11094 / 142620 (7.8%) | −324.0 | −324.0 | 3.05 |
| Spi1 SRX1131940 | Plasmablasts Blood | 1824 / 14262 (12.8%) | 5978 / 142620 (4.2%) | −324.0 | −324.0 | 3.05 |
| Bcl11b SRX2399085 | Thymocytes Blood | 3502 / 14262 (24.6%) | 11490 / 142620 (8.1%) | −324.0 | −324.0 | 3.05 |
| Lmo2 SRX1939444 | Lymphoid-primed multipotent progenitors Blood | 2111 / 14262 (14.8%) | 6934 / 142620 (4.9%) | −324.0 | −324.0 | 3.04 |
| Phf8 SRX2396657 | Prostate Prostate | 2133 / 14262 (15.0%) | 7010 / 142620 (4.9%) | −324.0 | −324.0 | 3.04 |
| Brd4 SRX1403500 | MLL-AF9 leukemic cell Blood | 2499 / 14262 (17.5%) | 8214 / 142620 (5.8%) | −324.0 | −324.0 | 3.04 |
| Spi1 SRX2499723 | Scid.adh.2c2 Blood | 2132 / 14262 (14.9%) | 7022 / 142620 (4.9%) | −324.0 | −324.0 | 3.04 |
| Kmt2a SRX17605403 | Granulocytic-monocytic progenitors Blood | 2932 / 14262 (20.6%) | 9664 / 142620 (6.8%) | −324.0 | −324.0 | 3.03 |
| Rela SRX6074119 | MEF Embryonic fibroblast | 2663 / 14262 (18.7%) | 8817 / 142620 (6.2%) | −324.0 | −324.0 | 3.02 |
| Max SRX9432515 | RAW 264.7 Blood | 2013 / 14262 (14.1%) | 6715 / 142620 (4.7%) | −324.0 | −324.0 | 3.00 |
| Spi1 SRX2499696 | Scid.adh.2c2 Blood | 2224 / 14262 (15.6%) | 7441 / 142620 (5.2%) | −324.0 | −324.0 | 2.99 |
| Spi1 SRX2499695 | Scid.adh.2c2 Blood | 2607 / 14262 (18.3%) | 8746 / 142620 (6.1%) | −324.0 | −324.0 | 2.98 |
| Runx1 SRX825830 | mESC derived haematopoietic progenitor Pluripotent stem cell | 1869 / 14262 (13.1%) | 6284 / 142620 (4.4%) | −324.0 | −324.0 | 2.97 |
| Nfib SRX19694892 | C3H/10T1/2 Embryonic fibroblast | 2404 / 14262 (16.9%) | 8120 / 142620 (5.7%) | −324.0 | −324.0 | 2.96 |
| Runx3 SRX7554475 | CD8+ T cells Blood | 2562 / 14262 (18.0%) | 8661 / 142620 (6.1%) | −324.0 | −324.0 | 2.96 |
| Ikzf3 SRX10166889 | Thymocytes Blood | 3173 / 14262 (22.2%) | 10736 / 142620 (7.5%) | −324.0 | −324.0 | 2.96 |
| Ctcf SRX10095030 | Bone Marrow Cells Blood | 3216 / 14262 (22.5%) | 10887 / 142620 (7.6%) | −324.0 | −324.0 | 2.95 |
| Pax5 SRX10950550 | Pro-B cells Blood | 2560 / 14262 (17.9%) | 8667 / 142620 (6.1%) | −324.0 | −324.0 | 2.95 |
| Ikzf1 SRX205987 | B cells Blood | 2592 / 14262 (18.2%) | 8803 / 142620 (6.2%) | −324.0 | −324.0 | 2.94 |
| Ikzf3 SRX10166886 | Thymocytes Blood | 2126 / 14262 (14.9%) | 7269 / 142620 (5.1%) | −324.0 | −324.0 | 2.92 |
| Rnf2 SRX3660768 | CD4 CD8 double negative cells Blood | 2364 / 14262 (16.6%) | 8088 / 142620 (5.7%) | −324.0 | −324.0 | 2.92 |
| Spi1 SRX2499682 | CD25+ cells Blood | 2002 / 14262 (14.0%) | 6884 / 142620 (4.8%) | −324.0 | −324.0 | 2.91 |
| Zfp384 SRX2324495 | Spermatogonia Gonad | 2084 / 14262 (14.6%) | 7169 / 142620 (5.0%) | −324.0 | −324.0 | 2.91 |
| Smc1a SRX7348145 | CD4 CD8 double positive cells Blood | 2356 / 14262 (16.5%) | 8112 / 142620 (5.7%) | −324.0 | −324.0 | 2.90 |
| Smarca4 SRX1815508 | B cells Blood | 3370 / 14262 (23.6%) | 11637 / 142620 (8.2%) | −324.0 | −324.0 | 2.90 |
| AML1-ETO SRX3491901 | Spleen Spleen | 2076 / 14262 (14.6%) | 7187 / 142620 (5.0%) | −324.0 | −324.0 | 2.89 |
| Sin3a SRX188801 | CH12 Blood | 2429 / 14262 (17.0%) | 8439 / 142620 (5.9%) | −324.0 | −324.0 | 2.88 |
| Med1 SRX1403502 | MLL-AF9 leukemic cell Blood | 2225 / 14262 (15.6%) | 7742 / 142620 (5.4%) | −324.0 | −324.0 | 2.87 |
| Ikzf1 SRX205986 | B cells Blood | 3013 / 14262 (21.1%) | 10531 / 142620 (7.4%) | −324.0 | −324.0 | 2.86 |
| Smc1a SRX7348146 | CD4 CD8 double positive cells Blood | 2446 / 14262 (17.2%) | 8557 / 142620 (6.0%) | −324.0 | −324.0 | 2.86 |
| Spi1 SRX2499697 | Scid.adh.2c2 Blood | 2628 / 14262 (18.4%) | 9255 / 142620 (6.5%) | −324.0 | −324.0 | 2.84 |
| Smc1a SRX7348144 | CD4 CD8 double positive cells Blood | 2568 / 14262 (18.0%) | 9070 / 142620 (6.4%) | −324.0 | −324.0 | 2.83 |
| Mxi1 SRX140391 | MEL Blood | 2394 / 14262 (16.8%) | 8460 / 142620 (5.9%) | −324.0 | −324.0 | 2.83 |
| Smc1a SRX7348143 | CD4 CD8 double positive cells Blood | 2393 / 14262 (16.8%) | 8466 / 142620 (5.9%) | −324.0 | −324.0 | 2.83 |
| Kmt2a SRX17605404 | Granulocytic-monocytic progenitors Blood | 2374 / 14262 (16.6%) | 8411 / 142620 (5.9%) | −324.0 | −324.0 | 2.82 |
| Epitope tags SRX6370145 | G1E Blood | 2541 / 14262 (17.8%) | 9029 / 142620 (6.3%) | −324.0 | −324.0 | 2.81 |
| Runx1 SRX310206 | Mast Cells Blood | 2992 / 14262 (21.0%) | 10633 / 142620 (7.5%) | −324.0 | −324.0 | 2.81 |
| Runx2 SRX17733008 | ATDC-5 Pluripotent stem cell | 2475 / 14262 (17.4%) | 8807 / 142620 (6.2%) | −324.0 | −324.0 | 2.81 |
| Smarca4 SRX8693962 | Neutrophils Blood | 2245 / 14262 (15.7%) | 8032 / 142620 (5.6%) | −324.0 | −324.0 | 2.80 |
| Spi1 SRX886478 | B-ALL Blood | 2931 / 14262 (20.6%) | 10493 / 142620 (7.4%) | −324.0 | −324.0 | 2.79 |
| Ascl1 SRX8886261 | Lung tumors Lung | 2407 / 14262 (16.9%) | 8618 / 142620 (6.0%) | −324.0 | −324.0 | 2.79 |
| Rnf2 SRX3660770 | Bone Marrow Cells Blood | 2043 / 14262 (14.3%) | 7318 / 142620 (5.1%) | −324.0 | −324.0 | 2.79 |
| Epitope tags SRX6370147 | G1E Blood | 2467 / 14262 (17.3%) | 8844 / 142620 (6.2%) | −324.0 | −324.0 | 2.79 |
| Gata3 SRX2499767 | Scid.adh.2c2 Blood | 2157 / 14262 (15.1%) | 7736 / 142620 (5.4%) | −324.0 | −324.0 | 2.79 |
| Phf8 SRX2396658 | Prostate Prostate | 2146 / 14262 (15.0%) | 7697 / 142620 (5.4%) | −324.0 | −324.0 | 2.79 |
| AML1-ETO SRX3491900 | Spleen Spleen | 2312 / 14262 (16.2%) | 8324 / 142620 (5.8%) | −324.0 | −324.0 | 2.78 |
| Phf8 SRX2396660 | Prostate Prostate | 2226 / 14262 (15.6%) | 8077 / 142620 (5.7%) | −324.0 | −324.0 | 2.76 |
| Bcl11b SRX2399084 | Thymocytes Blood | 4081 / 14262 (28.6%) | 14851 / 142620 (10.4%) | −324.0 | −324.0 | 2.75 |
| Runx3 SRX7554476 | CD8+ T cells Blood | 2611 / 14262 (18.3%) | 9546 / 142620 (6.7%) | −324.0 | −324.0 | 2.74 |
| Zfp384 SRX2324494 | Spermatogonia Gonad | 2302 / 14262 (16.1%) | 8428 / 142620 (5.9%) | −324.0 | −324.0 | 2.73 |
| Whsc1l1 SRX1114542 | MLL-AF9 leukemic cell Blood | 2863 / 14262 (20.1%) | 10501 / 142620 (7.4%) | −324.0 | −324.0 | 2.73 |
| Runx2 SRX17733007 | ATDC-5 Pluripotent stem cell | 2609 / 14262 (18.3%) | 9624 / 142620 (6.7%) | −324.0 | −324.0 | 2.71 |
| Spi1 SRX1056343 | 416B Blood | 2326 / 14262 (16.3%) | 8601 / 142620 (6.0%) | −324.0 | −324.0 | 2.70 |
| Spi1 SRX2499684 | CD25+ cells Blood | 2337 / 14262 (16.4%) | 8648 / 142620 (6.1%) | −324.0 | −324.0 | 2.70 |
| Spi1 SRX2499683 | CD25+ cells Blood | 2331 / 14262 (16.3%) | 8637 / 142620 (6.1%) | −324.0 | −324.0 | 2.70 |
| Nelfa SRX6714137 | Heart Cardiovascular | 2298 / 14262 (16.1%) | 8549 / 142620 (6.0%) | −324.0 | −324.0 | 2.69 |
| Hdac2 SRX1815513 | B cells Blood | 2993 / 14262 (21.0%) | 11166 / 142620 (7.8%) | −324.0 | −324.0 | 2.68 |
| Spi1 SRX2188529 | Pro-B cells Blood | 2213 / 14262 (15.5%) | 8274 / 142620 (5.8%) | −324.0 | −324.0 | 2.67 |
| Sin3a SRX188800 | MEL Blood | 2700 / 14262 (18.9%) | 10098 / 142620 (7.1%) | −324.0 | −324.0 | 2.67 |
| Chd4 SRX3660753 | Bone Marrow Cells Blood | 2220 / 14262 (15.6%) | 8309 / 142620 (5.8%) | −324.0 | −324.0 | 2.67 |
| Ep300 SRX183951 | Th1 Cells Blood | 2465 / 14262 (17.3%) | 9244 / 142620 (6.5%) | −324.0 | −324.0 | 2.67 |
| Spi1 SRX7368532 | B cells Blood | 2471 / 14262 (17.3%) | 9346 / 142620 (6.6%) | −324.0 | −324.0 | 2.64 |
| Chd4 SRX3660752 | CD4 CD8 double negative cells Blood | 2552 / 14262 (17.9%) | 9676 / 142620 (6.8%) | −324.0 | −324.0 | 2.64 |
| Runx1 SRX3660775 | CD4 CD8 double negative cells Blood | 3188 / 14262 (22.4%) | 12114 / 142620 (8.5%) | −324.0 | −324.0 | 2.63 |
| Runx1 SRX3195537 | CD4 CD8 double negative cells Blood | 3186 / 14262 (22.3%) | 12121 / 142620 (8.5%) | −324.0 | −324.0 | 2.63 |
| Kmt2d SRX17605402 | Leukemia Blood | 2378 / 14262 (16.7%) | 9054 / 142620 (6.3%) | −324.0 | −324.0 | 2.63 |
| Runx1 SRX3660776 | CD4 CD8 double negative cells Blood | 3122 / 14262 (21.9%) | 11888 / 142620 (8.3%) | −324.0 | −324.0 | 2.63 |
| Runx1 SRX3195539 | CD4 CD8 double negative cells Blood | 3121 / 14262 (21.9%) | 11885 / 142620 (8.3%) | −324.0 | −324.0 | 2.63 |
| Smarca4 SRX8693963 | Neutrophils Blood | 2466 / 14262 (17.3%) | 9394 / 142620 (6.6%) | −324.0 | −324.0 | 2.63 |
| Hdac2 SRX3660759 | CD4 CD8 double negative cells Blood | 2881 / 14262 (20.2%) | 10977 / 142620 (7.7%) | −324.0 | −324.0 | 2.62 |
| Ing5 SRX14210166 | ES cells Pluripotent stem cell | 2265 / 14262 (15.9%) | 8716 / 142620 (6.1%) | −324.0 | −324.0 | 2.60 |
| Rad21 SRX2755282 | B cells Blood | 2477 / 14262 (17.4%) | 9571 / 142620 (6.7%) | −324.0 | −324.0 | 2.59 |
| Nelfa SRX6714136 | Heart Cardiovascular | 2347 / 14262 (16.5%) | 9089 / 142620 (6.4%) | −324.0 | −324.0 | 2.58 |
| Nr3c1 SRX4615043 | Lung endothelial cells Cardiovascular | 2551 / 14262 (17.9%) | 9900 / 142620 (6.9%) | −324.0 | −324.0 | 2.58 |
| Hdac2 SRX3660760 | CD4 CD8 double negative cells Blood | 3216 / 14262 (22.5%) | 12513 / 142620 (8.8%) | −324.0 | −324.0 | 2.57 |
| Kdm1a SRX3660771 | CD4 CD8 double negative cells Blood | 2759 / 14262 (19.3%) | 10752 / 142620 (7.5%) | −324.0 | −324.0 | 2.57 |
| Smarcc1 SRX8673311 | Tumor Others | 2850 / 14262 (20.0%) | 11170 / 142620 (7.8%) | −324.0 | −324.0 | 2.55 |
| Chd4 SRX3660754 | Bone Marrow Cells Blood | 2570 / 14262 (18.0%) | 10142 / 142620 (7.1%) | −324.0 | −324.0 | 2.53 |
| Spi1 SRX7368539 | B cells Blood | 3038 / 14262 (21.3%) | 12010 / 142620 (8.4%) | −324.0 | −324.0 | 2.53 |
| Ctcf SRX10095027 | Bone Marrow Cells Blood | 3798 / 14262 (26.6%) | 15063 / 142620 (10.6%) | −324.0 | −324.0 | 2.52 |
| Kdm1a SRX3660772 | CD4 CD8 double negative cells Blood | 2858 / 14262 (20.0%) | 11363 / 142620 (8.0%) | −324.0 | −324.0 | 2.52 |
| Epitope tags SRX6370146 | G1E Blood | 2753 / 14262 (19.3%) | 10958 / 142620 (7.7%) | −324.0 | −324.0 | 2.51 |
| Nr3c1 SRX4615040 | Lung endothelial cells Cardiovascular | 2608 / 14262 (18.3%) | 10527 / 142620 (7.4%) | −324.0 | −324.0 | 2.48 |
| Runx1 SRX3660777 | Bone Marrow Cells Blood | 2505 / 14262 (17.6%) | 10163 / 142620 (7.1%) | −324.0 | −324.0 | 2.46 |
| Spi1 SRX2499685 | CD25+ cells Blood | 2785 / 14262 (19.5%) | 11408 / 142620 (8.0%) | −324.0 | −324.0 | 2.44 |
| Spi1 SRX310205 | Mast Cells Blood | 3422 / 14262 (24.0%) | 14209 / 142620 (10.0%) | −324.0 | −324.0 | 2.41 |
| Epitope tags SRX6370142 | G1E Blood | 2876 / 14262 (20.2%) | 12030 / 142620 (8.4%) | −324.0 | −324.0 | 2.39 |
| Epitope tags SRX6370144 | G1E Blood | 2892 / 14262 (20.3%) | 12105 / 142620 (8.5%) | −324.0 | −324.0 | 2.39 |
| Spi1 SRX1939448 | Lymphoid-primed multipotent progenitors Blood | 3124 / 14262 (21.9%) | 13521 / 142620 (9.5%) | −324.0 | −324.0 | 2.31 |
| Spi1 SRX7821062 | Hematopoietic progenitors Blood | 3123 / 14262 (21.9%) | 13518 / 142620 (9.5%) | −324.0 | −324.0 | 2.31 |
| Hdac2 SRX3660762 | Bone Marrow Cells Blood | 3034 / 14262 (21.3%) | 13137 / 142620 (9.2%) | −324.0 | −324.0 | 2.31 |
| Kdm1a SRX3660774 | Bone Marrow Cells Blood | 2937 / 14262 (20.6%) | 12720 / 142620 (8.9%) | −324.0 | −324.0 | 2.31 |
| Epitope tags SRX6370143 | G1E Blood | 3151 / 14262 (22.1%) | 13862 / 142620 (9.7%) | −324.0 | −324.0 | 2.27 |
| Hdac2 SRX3660761 | Bone Marrow Cells Blood | 2919 / 14262 (20.5%) | 12949 / 142620 (9.1%) | −324.0 | −324.0 | 2.25 |
| Runx1 SRX3660778 | Bone Marrow Cells Blood | 2958 / 14262 (20.7%) | 13156 / 142620 (9.2%) | −324.0 | −324.0 | 2.25 |
| Kat2a SRX1815524 | B cells Blood | 1235 / 14262 (8.7%) | 2927 / 142620 (2.1%) | −322.7 | −320.9 | 4.22 |
| Biotin SRX5578684 | ES cells Pluripotent stem cell | 1235 / 14262 (8.7%) | 2930 / 142620 (2.1%) | −322.5 | −320.7 | 4.22 |
| Brd4 SRX10701687 | Spleen Spleen | 1228 / 14262 (8.6%) | 2900 / 142620 (2.0%) | −322.1 | −320.3 | 4.23 |
| Taf1 SRX19028406 | ES cells Pluripotent stem cell | 1671 / 14262 (11.7%) | 5197 / 142620 (3.6%) | −321.7 | −319.9 | 3.22 |
| Chd4 SRX1815509 | B cells Blood | 1858 / 14262 (13.0%) | 6265 / 142620 (4.4%) | −321.7 | −319.9 | 2.97 |
| Med1 SRX1403503 | MLL-AF9 leukemic cell Blood | 1739 / 14262 (12.2%) | 5586 / 142620 (3.9%) | −321.2 | −319.4 | 3.11 |
| Smc1a SRX7348142 | Thymocytes Blood | 1944 / 14262 (13.6%) | 6779 / 142620 (4.8%) | −321.1 | −319.3 | 2.87 |
| Spi1 SRX2341954 | Hematopoietic Stem Cells Blood | 2095 / 14262 (14.7%) | 7697 / 142620 (5.4%) | −321.1 | −319.3 | 2.72 |
| Ascl1 SRX8886262 | Lung tumors Lung | 2050 / 14262 (14.4%) | 7422 / 142620 (5.2%) | −321.0 | −319.2 | 2.76 |
| Ikzf1 SRX692974 | CD4 CD8 double negative cells Blood | 1335 / 14262 (9.4%) | 3437 / 142620 (2.4%) | −320.2 | −318.4 | 3.88 |
| Kdm1a SRX3660773 | Bone Marrow Cells Blood | 2767 / 14262 (19.4%) | 12091 / 142620 (8.5%) | −320.2 | −318.4 | 2.29 |
| Spi1 SRX5026215 | Mast Cells Blood | 1549 / 14262 (10.9%) | 4547 / 142620 (3.2%) | −320.2 | −318.4 | 3.41 |
| Epitope tags SRX3219125 | RN2 Blood | 1382 / 14262 (9.7%) | 3674 / 142620 (2.6%) | −320.1 | −318.3 | 3.76 |
| Epitope tags SRX2357488 | Embryonic kidney Embryo | 1202 / 14262 (8.4%) | 2800 / 142620 (2.0%) | −319.5 | −317.7 | 4.29 |
| Biotin SRX5578683 | ES cells Pluripotent stem cell | 1246 / 14262 (8.7%) | 3011 / 142620 (2.1%) | −319.2 | −317.4 | 4.14 |
| Kmt2a SRX25655413 | Leukemia Blood | 1391 / 14262 (9.8%) | 3729 / 142620 (2.6%) | −319.2 | −317.4 | 3.73 |
| Runx1 DRX165596 | Unclassified Unclassified | 1299 / 14262 (9.1%) | 3269 / 142620 (2.3%) | −319.1 | −317.4 | 3.97 |
| Spi1 SRX5026214 | Mast Cells Blood | 1501 / 14262 (10.5%) | 4304 / 142620 (3.0%) | −319.0 | −317.2 | 3.49 |
| Brd4 SRX2522377 | Lymphoma cell lines Blood | 927 / 14262 (6.5%) | 1610 / 142620 (1.1%) | −318.8 | −317.0 | 5.76 |
| Brd4 SRX3602879 | iPS cells Pluripotent stem cell | 1069 / 14262 (7.5%) | 2208 / 142620 (1.5%) | −318.0 | −316.2 | 4.84 |
| Wdr5 SRX1815515 | B cells Blood | 1599 / 14262 (11.2%) | 4852 / 142620 (3.4%) | −317.3 | −315.5 | 3.30 |
| Smc1a SRX7348141 | Thymocytes Blood | 1956 / 14262 (13.7%) | 6908 / 142620 (4.8%) | −317.2 | −315.4 | 2.83 |
| Foxp3 SRX2341414 | Treg Blood | 1777 / 14262 (12.5%) | 5857 / 142620 (4.1%) | −317.0 | −315.2 | 3.03 |
| Erg SRX7821113 | Hematopoietic progenitors Blood | 1220 / 14262 (8.6%) | 2907 / 142620 (2.0%) | −316.9 | −315.2 | 4.20 |
| Erg SRX1939438 | Lymphoid-primed multipotent progenitors Blood | 1220 / 14262 (8.6%) | 2909 / 142620 (2.0%) | −316.7 | −314.9 | 4.19 |
| Runx1 SRX1901620 | G1E Blood | 1482 / 14262 (10.4%) | 4240 / 142620 (3.0%) | −315.6 | −313.8 | 3.50 |
| Nipbl SRX8694071 | B cells Blood | 1227 / 14262 (8.6%) | 2955 / 142620 (2.1%) | −315.3 | −313.5 | 4.15 |
| Ash2l SRX4816219 | Dorsal cortex Neural | 2111 / 14262 (14.8%) | 7896 / 142620 (5.5%) | −314.4 | −312.6 | 2.67 |
| Kdm1a SRX181863 | Granulocytes Blood | 1496 / 14262 (10.5%) | 4333 / 142620 (3.0%) | −313.9 | −312.1 | 3.45 |
| Kdm6a SRX16085105 | Hematopoietic progenitors Blood | 878 / 14262 (6.2%) | 1452 / 142620 (1.0%) | −313.4 | −311.6 | 6.05 |
| Hcfc1 SRX22870629 | Hepa 1-6 Liver | 1063 / 14262 (7.5%) | 2220 / 142620 (1.6%) | −313.0 | −311.2 | 4.79 |
| Ash2l SRX4816218 | Dorsal cortex Neural | 1534 / 14262 (10.8%) | 4564 / 142620 (3.2%) | −311.5 | −309.7 | 3.36 |
| Ncaph2 SRX1688321 | ES cells Pluripotent stem cell | 1771 / 14262 (12.4%) | 5894 / 142620 (4.1%) | −311.5 | −309.7 | 3.00 |
| Epitope tags SRX7713738 | Ba/F3 Blood | 984 / 14262 (6.9%) | 1893 / 142620 (1.3%) | −311.2 | −309.5 | 5.20 |
| Spi1 SRX2341957 | Hematopoietic Stem Cells Blood | 1787 / 14262 (12.5%) | 5995 / 142620 (4.2%) | −310.8 | −309.1 | 2.98 |
| Batf SRX10150717 | CD8+ T cells Blood | 1581 / 14262 (11.1%) | 4833 / 142620 (3.4%) | −310.5 | −308.7 | 3.27 |
| Spi1 SRX2341958 | Granulocytic-monocytic progenitors Blood | 2290 / 14262 (16.1%) | 9093 / 142620 (6.4%) | −310.4 | −308.6 | 2.52 |
| Rad21 SRX7481994 | Pro-B cells Blood | 1873 / 14262 (13.1%) | 6508 / 142620 (4.6%) | −310.3 | −308.6 | 2.88 |
| Rnf2 SRX3660769 | Bone Marrow Cells Blood | 1876 / 14262 (13.2%) | 6534 / 142620 (4.6%) | −309.7 | −308.0 | 2.87 |
| Rad21 SRX3753624 | B cells Blood | 2648 / 14262 (18.6%) | 11478 / 142620 (8.0%) | −309.7 | −307.9 | 2.31 |
| Sin3a SRX22262962 | Beta-TC-6 Pancreas | 1261 / 14262 (8.8%) | 3171 / 142620 (2.2%) | −309.7 | −307.9 | 3.98 |
| Batf SRX10150718 | CD8+ T cells Blood | 1548 / 14262 (10.9%) | 4664 / 142620 (3.3%) | −309.4 | −307.7 | 3.32 |
| Bcl11b SRX1677236 | Thymus Blood | 1051 / 14262 (7.4%) | 2199 / 142620 (1.5%) | −308.8 | −307.1 | 4.78 |
| Rag2 SRX018807 | Thymocytes Blood | 940 / 14262 (6.6%) | 1732 / 142620 (1.2%) | −308.1 | −306.3 | 5.43 |
| Ep300 SRX8379017 | Macrophages Blood | 2384 / 14262 (16.7%) | 9742 / 142620 (6.8%) | −308.0 | −306.3 | 2.45 |
| Epitope tags SRX4042634 | Endometriotic lesions Uterus | 1900 / 14262 (13.3%) | 6701 / 142620 (4.7%) | −308.0 | −306.2 | 2.84 |
| Brd4 SRX2172627 | iPS cells Pluripotent stem cell | 1438 / 14262 (10.1%) | 4090 / 142620 (2.9%) | −308.0 | −306.2 | 3.52 |
| Asxl1 SRX2837022 | Mesenchymal stem cells Others | 1628 / 14262 (11.4%) | 5132 / 142620 (3.6%) | −307.3 | −305.6 | 3.17 |
| Epitope tags SRX9195292 | ES cells Pluripotent stem cell | 1387 / 14262 (9.7%) | 3831 / 142620 (2.7%) | −307.3 | −305.5 | 3.62 |
| Med23 SRX20509321 | CH12 Blood | 1356 / 14262 (9.5%) | 3673 / 142620 (2.6%) | −307.1 | −305.3 | 3.69 |
| Kmt2a SRX25655410 | Leukemia Blood | 1342 / 14262 (9.4%) | 3604 / 142620 (2.5%) | −306.8 | −305.1 | 3.72 |
| Brd4 SRX5782039 | Leukemia stem cell lines Blood | 592 / 14262 (4.2%) | 531 / 142620 (0.4%) | −306.8 | −305.1 | 11.15 |
| Asxl1 SRX1471726 | Mesenchymal stem cells Others | 1627 / 14262 (11.4%) | 5133 / 142620 (3.6%) | −306.8 | −305.0 | 3.17 |
| Biotin SRX10950530 | Pro-B cells Blood | 1445 / 14262 (10.1%) | 4141 / 142620 (2.9%) | −306.7 | −304.9 | 3.49 |
| Fli1 SRX884086 | MLL-AF9 leukemic cell Blood | 2888 / 14262 (20.2%) | 13198 / 142620 (9.3%) | −306.5 | −304.8 | 2.19 |
| Ctcf SRX2172642 | Retina Neural | 2519 / 14262 (17.7%) | 10666 / 142620 (7.5%) | −306.5 | −304.8 | 2.36 |
| Hcfc1 SRX188798 | MEL Blood | 1700 / 14262 (11.9%) | 5557 / 142620 (3.9%) | −305.9 | −304.2 | 3.06 |
| Egr2 SRX270569 | CD4+ T cells Blood | 1579 / 14262 (11.1%) | 4884 / 142620 (3.4%) | −305.2 | −303.5 | 3.23 |
| Ep300 SRX8379016 | Macrophages Blood | 2302 / 14262 (16.1%) | 9271 / 142620 (6.5%) | −304.4 | −302.7 | 2.48 |
| Phf8 SRX15939565 | NIH/3T3 Embryonic fibroblast | 1215 / 14262 (8.5%) | 3000 / 142620 (2.1%) | −303.9 | −302.2 | 4.05 |
| Hcfc1 SRX188815 | CH12 Blood | 1825 / 14262 (12.8%) | 6311 / 142620 (4.4%) | −303.8 | −302.1 | 2.89 |
| Spi1 SRX2997922 | Hematopoietic Stem Cells Blood | 3026 / 14262 (21.2%) | 14241 / 142620 (10.0%) | −303.4 | −301.6 | 2.12 |
| Kdm6a SRX16085103 | Hematopoietic progenitors Blood | 887 / 14262 (6.2%) | 1551 / 142620 (1.1%) | −303.1 | −301.4 | 5.72 |
| Gfi1 SRX093162 | Bone Marrow Cells Blood | 1811 / 14262 (12.7%) | 6241 / 142620 (4.4%) | −303.0 | −301.3 | 2.90 |
| Spi1 SRX12298594 | B cells Blood | 1863 / 14262 (13.1%) | 6553 / 142620 (4.6%) | −302.8 | −301.1 | 2.84 |
| Epitope tags DRX165598 | Unclassified Unclassified | 1176 / 14262 (8.2%) | 2826 / 142620 (2.0%) | −302.4 | −300.7 | 4.16 |
| Kdm2b SRX22719874 | Leukemia Blood | 1493 / 14262 (10.5%) | 4451 / 142620 (3.1%) | −302.0 | −300.2 | 3.35 |
| Spi1 SRX1465791 | B cells Blood | 1353 / 14262 (9.5%) | 3711 / 142620 (2.6%) | −301.9 | −300.2 | 3.65 |
| Nelfb SRX11921266 | Naive T cells Blood | 1132 / 14262 (7.9%) | 2623 / 142620 (1.8%) | −301.9 | −300.1 | 4.32 |
| Biotin SRX273254 | B cells Blood | 2765 / 14262 (19.4%) | 12439 / 142620 (8.7%) | −301.5 | −299.8 | 2.22 |
| Epitope tags SRX11667686 | Pre-B cells Blood | 1010 / 14262 (7.1%) | 2076 / 142620 (1.5%) | −301.3 | −299.6 | 4.87 |
| Tmem131 SRX3219121 | RN2 Blood | 1296 / 14262 (9.1%) | 3427 / 142620 (2.4%) | −301.2 | −299.5 | 3.78 |
| Runx1 SRX2499763 | Scid.adh.2c2 Blood | 1247 / 14262 (8.7%) | 3185 / 142620 (2.2%) | −300.9 | −299.2 | 3.92 |
| Brd4 SRX1597806 | MLL-AF9 leukemic cell Blood | 1999 / 14262 (14.0%) | 7407 / 142620 (5.2%) | −300.9 | −299.2 | 2.70 |
| Myc SRX353782 | B cells Blood | 1078 / 14262 (7.6%) | 2384 / 142620 (1.7%) | −300.7 | −299.0 | 4.52 |
| Spi1 SRX2341955 | Hematopoietic Stem Cells Blood | 1939 / 14262 (13.6%) | 7046 / 142620 (4.9%) | −300.5 | −298.8 | 2.75 |
| Pax5 SRX7809234 | Pro-B cells Blood | 1395 / 14262 (9.8%) | 3947 / 142620 (2.8%) | −300.3 | −298.5 | 3.53 |
| Kmt2a SRX25655412 | Leukemia Blood | 1260 / 14262 (8.8%) | 3257 / 142620 (2.3%) | −300.1 | −298.4 | 3.87 |
| Epitope tags SRX2486173 | ES cells Pluripotent stem cell | 1748 / 14262 (12.3%) | 5913 / 142620 (4.1%) | −299.9 | −298.2 | 2.96 |
| Cbfb SRX5780109 | CD4+ T cells Blood | 1185 / 14262 (8.3%) | 2893 / 142620 (2.0%) | −299.8 | −298.1 | 4.10 |
| Ep300 SRX7726459 | Natural killer cells Blood | 1723 / 14262 (12.1%) | 5772 / 142620 (4.0%) | −299.6 | −297.9 | 2.99 |
| Kmt2a SRX11002576 | Leukemia Blood | 1126 / 14262 (7.9%) | 2615 / 142620 (1.8%) | −299.5 | −297.8 | 4.31 |
| Biotin SRX13366572 | Plasmablasts Blood | 1788 / 14262 (12.5%) | 6166 / 142620 (4.3%) | −298.6 | −296.9 | 2.90 |
| Fli1 SRX4705106 | MLL-AF9 leukemic cell Blood | 1394 / 14262 (9.8%) | 3961 / 142620 (2.8%) | −298.5 | −296.8 | 3.52 |
| Spi1 SRX2341959 | Granulocytic-monocytic progenitors Blood | 2358 / 14262 (16.5%) | 9750 / 142620 (6.8%) | −297.9 | −296.2 | 2.42 |
| Nfya SRX12799801 | Acute myeloid leukemia Blood | 1462 / 14262 (10.3%) | 4330 / 142620 (3.0%) | −297.9 | −296.2 | 3.38 |
| Myc SRX8012787 | Fibroblasts Others | 1493 / 14262 (10.5%) | 4502 / 142620 (3.2%) | −297.6 | −295.8 | 3.32 |
| Epitope tags SRX24288475 | Pro-B cells Blood | 1243 / 14262 (8.7%) | 3198 / 142620 (2.2%) | −297.5 | −295.8 | 3.89 |
| Biotin SRX3410337 | Pre-B cells Blood | 1318 / 14262 (9.2%) | 3578 / 142620 (2.5%) | −297.3 | −295.6 | 3.68 |
| Epitope tags SRX11667696 | Pre-B cells Blood | 1106 / 14262 (7.8%) | 2548 / 142620 (1.8%) | −296.4 | −294.7 | 4.34 |
| Tcf7 SRX24130479 | Thymocytes Blood | 1357 / 14262 (9.5%) | 3789 / 142620 (2.7%) | −296.4 | −294.7 | 3.58 |
| Epitope tags SRX15596410 | MEF Embryonic fibroblast | 1230 / 14262 (8.6%) | 3145 / 142620 (2.2%) | −296.3 | −294.6 | 3.91 |
| Fli1 SRX884087 | MLL-AF9 leukemic cell Blood | 3196 / 14262 (22.4%) | 15628 / 142620 (11.0%) | −296.3 | −294.6 | 2.05 |
| Spi1 SRX8030788 | Acute myeloid leukemia Blood | 1977 / 14262 (13.9%) | 7352 / 142620 (5.2%) | −295.5 | −293.8 | 2.69 |
| Dmc1 SRX3630644 | Testis Gonad | 1808 / 14262 (12.7%) | 6331 / 142620 (4.4%) | −295.3 | −293.6 | 2.86 |
| Erg SRX884089 | MLL-AF9 leukemic cell Blood | 3336 / 14262 (23.4%) | 16700 / 142620 (11.7%) | −294.6 | −292.9 | 2.00 |
| Chd4 SRX3660751 | CD4 CD8 double negative cells Blood | 1834 / 14262 (12.9%) | 6498 / 142620 (4.6%) | −294.5 | −292.8 | 2.82 |
| Brd4 SRX3113705 | CD4+ T cells Blood | 866 / 14262 (6.1%) | 1523 / 142620 (1.1%) | −294.4 | −292.7 | 5.69 |
| Spi1 SRX2499688 | CD25+ cells Blood | 1539 / 14262 (10.8%) | 4796 / 142620 (3.4%) | −294.1 | −292.4 | 3.21 |
| Tead4 SRX3459538 | Liver Liver | 737 / 14262 (5.2%) | 1043 / 142620 (0.7%) | −293.6 | −291.9 | 7.07 |
| Tcf7 SRX24130478 | Thymocytes Blood | 1324 / 14262 (9.3%) | 3653 / 142620 (2.6%) | −293.1 | −291.4 | 3.62 |
| Phf8 SRX15939564 | NIH/3T3 Embryonic fibroblast | 1190 / 14262 (8.3%) | 2984 / 142620 (2.1%) | −292.5 | −290.8 | 3.99 |
| Epitope tags SRX9195279 | ES cells Pluripotent stem cell | 1555 / 14262 (10.9%) | 4906 / 142620 (3.4%) | −292.4 | −290.7 | 3.17 |
| Kmt2a SRX25655409 | Leukemia Blood | 1256 / 14262 (8.8%) | 3319 / 142620 (2.3%) | −291.8 | −290.1 | 3.78 |
| Pax5 SRX7809235 | Pro-B cells Blood | 1391 / 14262 (9.8%) | 4021 / 142620 (2.8%) | −291.5 | −289.8 | 3.46 |
| Sp1 SRX7799921 | CH12 Blood | 1726 / 14262 (12.1%) | 5899 / 142620 (4.1%) | −291.4 | −289.8 | 2.93 |
| Taf1 SRX11221947 | ES cells Pluripotent stem cell | 1674 / 14262 (11.7%) | 5604 / 142620 (3.9%) | −290.9 | −289.2 | 2.99 |
| Irf4 SRX2162564 | Pre-B cells Blood | 2383 / 14262 (16.7%) | 10052 / 142620 (7.0%) | −290.2 | −288.5 | 2.37 |
| Ikzf1 SRX20340935 | Pre-B cells Blood | 1362 / 14262 (9.5%) | 3885 / 142620 (2.7%) | −289.9 | −288.2 | 3.51 |
| Cebpa SRX8005881 | Macrophages Blood | 1710 / 14262 (12.0%) | 5824 / 142620 (4.1%) | −289.9 | −288.2 | 2.94 |
| Spi1 SRX5026212 | Mast Cells Blood | 1342 / 14262 (9.4%) | 3781 / 142620 (2.7%) | −289.8 | −288.2 | 3.55 |
| Eomes SRX4510927 | OT-1 Blood | 1950 / 14262 (13.7%) | 7282 / 142620 (5.1%) | −289.2 | −287.5 | 2.68 |
| Tcf3 SRX1568859 | B cells Blood | 1516 / 14262 (10.6%) | 4737 / 142620 (3.3%) | −288.4 | −286.8 | 3.20 |
| Phf6 SRX1426206 | Pre-B cells Blood | 1604 / 14262 (11.2%) | 5233 / 142620 (3.7%) | −288.4 | −286.7 | 3.07 |
| Spi1 SRX2997920 | Hematopoietic Stem Cells Blood | 3071 / 14262 (21.5%) | 14900 / 142620 (10.4%) | −288.0 | −286.3 | 2.06 |
| Ikzf1 SRX2162555 | Pre-B cells Blood | 1364 / 14262 (9.6%) | 3917 / 142620 (2.7%) | −288.0 | −286.3 | 3.48 |
| Runx3 SRX338019 | Natural killer cells Blood | 986 / 14262 (6.9%) | 2073 / 142620 (1.5%) | −287.9 | −286.2 | 4.76 |
| Rnf2 SRX7278120 | Hematopoietic progenitors Blood | 804 / 14262 (5.6%) | 1322 / 142620 (0.9%) | −287.8 | −286.1 | 6.08 |
| Taf1 SRX19028409 | ES cells Pluripotent stem cell | 1806 / 14262 (12.7%) | 6427 / 142620 (4.5%) | −287.7 | −286.0 | 2.81 |
| Brd4 SRX10701688 | Spleen Spleen | 964 / 14262 (6.8%) | 1983 / 142620 (1.4%) | −287.1 | −285.4 | 4.86 |
| Ikzf1 SRX149203 | B3 Blood | 998 / 14262 (7.0%) | 2139 / 142620 (1.5%) | −286.3 | −284.6 | 4.67 |
| Foxp3 SRX3829344 | Treg Blood | 1093 / 14262 (7.7%) | 2575 / 142620 (1.8%) | −286.2 | −284.6 | 4.24 |
| Spi1 SRX8693957 | Neutrophils Blood | 2089 / 14262 (14.6%) | 8216 / 142620 (5.8%) | −285.5 | −283.8 | 2.54 |
| Spi1 SRX2980171 | Myeloid leukemia Blood | 2504 / 14262 (17.6%) | 10959 / 142620 (7.7%) | −285.3 | −283.7 | 2.28 |
| Spi1 SRX2997919 | Hematopoietic Stem Cells Blood | 2931 / 14262 (20.6%) | 13948 / 142620 (9.8%) | −285.3 | −283.7 | 2.10 |
| GFP SRX2486156 | C127 Breast | 881 / 14262 (6.2%) | 1644 / 142620 (1.2%) | −285.3 | −283.6 | 5.36 |
| Sin3a SRX9450272 | ES cells Pluripotent stem cell | 2021 / 14262 (14.2%) | 7788 / 142620 (5.5%) | −285.3 | −283.6 | 2.60 |
| Epitope tags SRX4042635 | Endometrium Uterus | 1796 / 14262 (12.6%) | 6411 / 142620 (4.5%) | −284.5 | −282.9 | 2.80 |
| Ezh2 SRX14407152 | T cell lymphoma cells Blood | 893 / 14262 (6.3%) | 1699 / 142620 (1.2%) | −284.5 | −282.8 | 5.26 |
| Tet1 SRX3202004 | ES cells Pluripotent stem cell | 1646 / 14262 (11.5%) | 5528 / 142620 (3.9%) | −284.4 | −282.7 | 2.98 |
| Spi1 SRX5026213 | Mast Cells Blood | 1292 / 14262 (9.1%) | 3580 / 142620 (2.5%) | −284.2 | −282.6 | 3.61 |
| Spi1 SRX2499720 | Scid.adh.2c2 Blood | 1401 / 14262 (9.8%) | 4158 / 142620 (2.9%) | −284.1 | −282.4 | 3.37 |
| Kdm4b SRX7794503 | Mesenchymal stem cells Others | 1386 / 14262 (9.7%) | 4078 / 142620 (2.9%) | −284.0 | −282.4 | 3.40 |
| Taf3 SRX13439131 | ES cells Pluripotent stem cell | 2631 / 14262 (18.4%) | 11858 / 142620 (8.3%) | −283.9 | −282.3 | 2.22 |
| Max SRX140382 | MEL Blood | 1829 / 14262 (12.8%) | 6626 / 142620 (4.6%) | −283.6 | −281.9 | 2.76 |
| Taf12 SRX11221943 | ES cells Pluripotent stem cell | 1082 / 14262 (7.6%) | 2549 / 142620 (1.8%) | −283.3 | −281.6 | 4.24 |
| Epitope tags SRX9195293 | ES cells Pluripotent stem cell | 1206 / 14262 (8.5%) | 3153 / 142620 (2.2%) | −283.2 | −281.5 | 3.82 |
| Ep300 SRX1565832 | Natural killer cells Blood | 1762 / 14262 (12.4%) | 6230 / 142620 (4.4%) | −283.0 | −281.4 | 2.83 |
| Stat5a SRX17605414 | Leukemia Blood | 1630 / 14262 (11.4%) | 5459 / 142620 (3.8%) | −282.6 | −280.9 | 2.99 |
| Ep300 SRX1565831 | Natural killer cells Blood | 1841 / 14262 (12.9%) | 6714 / 142620 (4.7%) | −282.6 | −280.9 | 2.74 |
Showing first 500 of 11551 rows.